THAR insider files Form 4 reporting 90,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tharimmune (THAR) insider Vincent LoPriore filed a Form 4 reporting a grant of 90,000 stock options at an exercise price of $3.075 on 11/03/2025. The options are exercisable on 11/03/2025 and expire on 11/03/2035.
Following the transaction, LoPriore beneficially owned 190,000 derivative securities, held directly. He is listed as Executive Chairman, Director, and a 10% Owner.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
LoPriore Vincent S
Role
Executive Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 90,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 190,000 shares (Direct)
Footnotes (1)
FAQ
What did THAR report in this Form 4?
An insider, Vincent LoPriore, reported receiving 90,000 stock options at an exercise price of $3.075 on 11/03/2025.
What are the key dates for the reported THAR options?
The options are exercisable on 11/03/2025 and expire on 11/03/2035.
How many derivative securities does the insider own after the transaction?
LoPriore beneficially owned 190,000 derivative securities following the reported transaction.
What is the insider’s relationship to Tharimmune (THAR)?
He is an Executive Chairman, Director, and a 10% Owner.
What ownership form is indicated for the reported securities?
The ownership form is listed as Direct (D).